Trial intelligence / Profile preview

Tapentadol IR for Postoperative Pain Following Bunionectomy

NCT00609466Phase 3Completed

Sponsor
Grünenthal GmbH
Start
Sep 2007
Primary completion
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tapentadol in postoperative pain (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Sum of Pain Intensity Differences Relative to the Baseline Pain Intensity over 48 Hours. Started Sep 2007; status: completed.

02

Drugs

tapentadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00609466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00609466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call